Vaccines: for veterinary medicine

In 2024, vaccines: for veterinary medicine trade exhibited modest growth, with global flows reaching $5,110,505,147 and a three-year compound annual growth rate of +6.5% (five-year: +6.0%). The all-time peak of $5,110,505,147 was recorded in 2024.

Over the 30-year observation window (1995–2024), 83% of years recorded positive growth, indicating a predominantly expanding market. Trend momentum is steady (+2.4% acceleration).

The World Trade Flows Characterization classifies vaccines: for veterinary medicine as "One-way trade" in the medium price range price segment, providing additional context for market positioning and competitive dynamics.

The supply side is diversified (Herfindahl-Hirschman Index 0.107). The three largest exporters — Netherlands ($1.1B), United States ($957.2M), and Spain ($531.9M) — collectively dominate supply flows. The leading exporter has grown at +15.5% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.022). The three largest import markets are France ($255.5M), Netherlands ($221.9M), and Brazil ($219.8M). The largest importing market sources from 33 different supplying countries.

Estimated substitution elasticity: -31.68. Buyers are highly price-sensitive and can switch between suppliers relatively easily.

The dominant trade corridor is United States → Mexico at $110.3M, representing 64.2% of the importer's total demand.

The volatility score for vaccines: for veterinary medicine is 12 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, modest but steady demand provides a reasonable entry window. The diversified supply landscape means many competitors but also multiple entry points and buyer relationships to target.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.